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ABSTRACT
OBJECTIVE: The objective of this systematic review is to determine whether or not local
infiltration analgesia (LIA) is a safe and effective method for post-operative pain management
after a unilateral total knee arthroplasty (TKA).
STUDY DESIGN: Review of three English language primary studies published in 2010 and
2011.
DATA SOURCES: Three randomized controlled trials comparing local infiltration analgesia to
three separate controls: epidural analgesia, placebo infiltration and femoral nerve block found
using PubMed.
OUTCOMES MEASURED: Clinical outcome was measured by total morphine use
postoperatively and average knee pain intensity at rest and upon movement postoperatively.
Total morphine use in milligrams used postoperatively was determined by amount used via IV
PCA pump; each study differed upon postoperative follow-up periods. Average knee pain
intensity at rest and upon movement was measured by subjective average VAS/NRS scores (0100 mm visual analog scale; 0 = no pain, 100 = worst pain imaginable). Studies varied among
postoperative time periods when VAS score was recorded from each patient. Data was analyzed
with Mann-Whitney U-test.
RESULTS: In the study by Affas et al, LIA was found to have similar analgesic effects
measured by average pain intensity and average total morphine use during first post-operative 24
hours, as the control femoral nerve block technique, but not to the point of statistical
significance. In the study by Essving et al, the LIA group had a median morphine consumption
during the first 48 hours postoperatively statistically significantly less than the placebo group.
LIA also proved to have statistically significantly lower median VAS pain scores than the
placebo group postoperatively. In the study by Andersen et al, morphine consumption and
average VAS scores at rest and during mobilization were statistically significantly lower in
group A (LIA) versus the control group (epidural analgesia).
CONCLUSIONS: The results of two of the RCTs show local infiltration analgesia to be an
effective method for post-operative pain management after a unilateral TKA (Essving and
Andersen).6,7 One RCT does not reach statistical significance (Affas).5 Safety of LIA was
demonstrated with minimal ADR’s in all RCTs.5,6,7
KEY WORDS: Local infiltration analgesia, Total Knee Arthroplasty
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INTRODUCTION
Total knee arthroplasty (TKA), also known as a total knee replacement, is a common
orthopedic procedure performed to treat pathologic conditions of the knee for pain relief and
restoration of knee mobility and function.1 This paper encompasses three randomized controlled
trials comparing the efficacy of local infiltration analgesia (LIA) as a post-operative pain
management technique with femoral nerve block, placebo injections and epidural infusions. The
consideration of pain relief management post-operatively for patients undergoing a total knee
arthroplasty is an important topic to discuss in regards to the increasingly common nature of
TKA among our aging population and the rise in physician assistant employment in the field of
orthopedics. According to the Agency for Healthcare Research and Quality, more than 600,000
knee replacements are performed each year in the United States.2 Not only are total knee
arthroplasties extremely commonplace nowadays, the price for the surgery on a single knee is
practically unaffordable without health insurance. The average cost in the United States for a
unilateral total knee arthroplasty (TKA) ranges from $45,000- $70,000 with no health insurance.3
Usually, total knee arthroplasty is the last resort in management of patients with medical
conditions that typically lead to deterioration of the essential hinge joint. The primary pathologic
conditions that commonly predispose patients to necessitating TKA include osteoarthritis
(idiopathic and post-traumatic), rheumatoid arthritis, psoriatic arthritis, avascular necrosis,
tumors or congenital deformities.1 Common indications for TKA primarily include pain relief
(significant and disabling pain that reduces patients’ quality of life), correction of significant
deformity, older patients with modest activity levels and younger patients who have limitation of
function due to systemic arthritis.4 The decision to undergo the a TKA is ultimately made
between the patient and the orthopedic surgeon performing the procedure.
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In the realm of pain control and anesthesia, a total knee arthroplasty has a few options
and approaches that can be taken in order for a patient to undergo the operation. Currently,
patients undergo TKA with regional or general anesthesia. The decision to use regional or
general anesthesia is decided among the patient and surgical team as well as taking the patient’s
medical condition into consideration for the best outcome.4 Epidural anesthesia and femoral
nerve blocks have been the primary methods of analgesia for patient’s undergoing TKA.
Epidural anesthesia has been shown to prevent the development of fewer DVT’s and the constant
indwelling catheter provides better pain relief control post-operatively as compared to other
analgesic methods.4 Continuous femoral nerve block with perineural ropivacaine 0.2% is shown
to reduce pain, lower morphine use post-operatively and decrease time to discharge following
TKA as opposed to placebo methods.4
The proposed method of treatment for TKA post-operative pain is effective, easy to
administer and evidence supports its superiority to traditional pain control methods. Local
infiltration analgesia (LIA) is an analgesic method administered intra- and periarticularly during
the TKA operation (with ropivacaine, ketorolac and epinephrine).5,6,7 LIA is shown among the
three RCT’s to provide comparable or superior pain relief and decrease morphine consumption
postoperatively in patients undergoing unilateral TKA in comparison to the traditional pain
relieving methods.5,6,7
OBJECTIVE
The objective of this systematic review is to determine whether or not local infiltration
analgesia (LIA) is a safe and effective method for post-operative pain management after a
unilateral total knee arthroplasty (TKA).
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METHODS
In order to find adequate information for the research of this topic, a set of criteria was used
for selection of contributory studies. The populations in the studies encompass male and female
patients undergoing unilateral total knee arthroplasty, over age 18. The common intervention
among all of the studies includes the objective intervention being studied, local infiltration
analgesia (LIA). The comparison interventions in each of the three randomized controlled trials
to local infiltration analgesia (LIA) includes femoral nerve block with ropivacaine directly after
spinal anesthesia, no injections given intra-operatively and epidural infusion (4 mL/h) of 192 mL
ropivacaine (2 mg/mL) combined with 6 intravenous administrations of 0.5 mL ketorolac (30
mg/mL) for 48 h postoperatively, respectively.
All three studies utilized for research are randomized controlled trials (RCT). Data sources
for the systematic review were selected from PubMed and the Cochrane Library. Key words
used to search for the articles included “total knee arthroplasty” and “local infiltration analgesia”.
All articles were published in peer-reviewed journals and in English. Articles were selected on
their clinical relevance and inclusion of my selected patient-oriented evidence that matters
(POEMS), specific to my clinical question. Inclusion criteria for the studies are patients > 18
years of age scheduled for elective, unilateral total knee arthroplasty.5,6,7 Exclusion criteria
encompasses hypersensitivity to study drugs, serious liver, heart or renal disease, epilepsy,
mental disorder, language difficulty, dementia, QT interval on ECG > 450 msec before start,
inflammatory joint disease, chronic pain, bleeding disorder, contraindications to spinal
anesthesia and epidural analgesia, regular narcotic use, drug-treated diabetes, neuropathic pain or
sensory disorders in the leg to be operated on, RA, pregnancy, severe obesity (BMI > 40),
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treatment with tricyclic antidepressants, antiepileptic drugs and/or antacids.5,6,7 A summary of the
statistics reported or used in the three randomized controlled studies include RRR, ARR, NNT
and p-values.
Table 1: Demographics & Characteristics of included studies
Study

Type

#
Pts
40

Age (yrs)

Inclusion Criteria

Exclusion Criteria

Affas5
(2011)

RCT

Essvin
g6
(2010)

Anders
en7
(2010)

W/
D
0

Interventions

67 ± 21-38
years

Allergy or intolerance to one
of the study drugs, Renal
insufficiency, Epilepsy,
Language difficulty, Mental
illness, Dementia, QT interval
on ECG > 450 msec before
start

RCT
(doubl
eblind)

48

70± 9 years

Patients with
osteoarthritis or
rheumatoid arthritis
scheduled for primary
unilateral elective total
knee arthroplasty under
spinal anesthesia,
American Society of
Anesthesiologists (ASA)
classification I-III, and
more than 18 years old
Patients schedule for total
knee arthroplasty (TKA)
because of osteoarthritis
age 20-85 years old, ASA
I-III and normal
preoperative mobility

Known allergy or intolerance
to one of the study drugs,
Serious liver, heart or renal
disease, Inflammatory joint
disease, Chronic pain,
Bleeding disorder

1

Hypersensitivity to study
drugs, Contraindications to
spinal anesthesia and epidural
analgesia, regular narcotic use,
general anesthesia, Inability to
communicate in Danish, Drugtreated diabetes, Neuropathic
pain or sensory disorders in
the leg to be operated on, RA,
Pregnancy, Severe obesity
(BMI > 40), Treatment with
tricyclic antidepressants,
antiepileptic drugs and/or
antacids

7

Group A: 400 mg
ropivacaine, 30 mg
ketorolac, and 0.5 mg
epinephrine were
infiltrated periarticularly
during operation 21 hr
postoperatively: 200 mg
ropivacaine, 30 mg
ketorolac, and 0.1 mg
epinephrine were injected
intraarticularly
Group A: intraoperative
wound infiltration with
150 mL ropivacaine (2
mg/mL), 1 mL ketorolac
(30 mg/mL) and 0.5 mL
epinephrine (1 mg/mL)
(total volume 152 mL)
combined with intraarticular infusion (4
mL/h) of 190 mL
ropivacaine (2 mg/mL)
plus 2 mL ketorolac (30
mg/mL)

RCT

40

67± 5 years

40 patients > 18 years of
age undergoing elective,
unilateral, primary TKA

Group LIA: received periand intra-articular
infiltration with
ropivacaine + ketorolac
and epinephrine

OUTCOMES
The outcomes of the studies that were measured included total morphine used
postoperatively and the average knee pain intensity at rest and upon movement postoperatively.
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The outcomes were measured by total PCA-morphine consumption recordings during specific
intervals in the postoperative period and with an average pain assessment VAS/NRS score (0100 mm VAS) at rest and upon movement (analyzed with Mann-Whitney U-test).
RESULTS
The three randomized controlled trials chosen for this systematic review compare local
infiltration analgesia (LIA) against three differing control interventions: femoral nerve block,
placebo injections and epidural analgesia.
The first study (Affas et al) was conducted over a twenty-four hour period
postoperatively from an elective TKA. Forty patients were randomized into either experimental
group LIA, receiving peri- or intra-articular infiltration analgesia with a mixture containing 150
mL ropivacaine (2 mg/mL), 1 mL ketorolac (30 mg/mL) and 5 mL epinephrine (0.1 mg/mL) or
group F, in which patients received a femoral nerve block directly after spinal analgesia [30 mL
ropivacaine (2 mg/mL) was injected followed by 15 mL of the same concentration every 4 hours
for 24 hours (total dose 240 mg/24 hours)].5 The primary outcome for this study was average
pain intensity 24 hours postoperatively between group LIA and group F; measurements were
recorded using NRS (numeric rating scale) from 0-10 (0 = no pain and 10= worst pain
imaginable), on an hourly basis postoperatively if the patient was awake. If the patient were
asleep, the NRS score was recorded as a “0”.5 The secondary outcome, or total morphine use 24
hours post-TKA was quantified by the intravenous PCA pump and analyzed by the MannWhitney U-test.
All of the 40 patients who entered the study completed the operation and trial. Data was
analyzed under strict intention-to-treat (sITT).5 A value of p < 0.05 was chosen to indicate
statistical significance and confidence intervals of 95%. For the primary outcome of the study
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comparing average pain NRS at rest and upon movement, the study revealed similar low average
pain intensity scores at rest among Group F and group LIA. Group F had an average NRS score
at rest of 2.1 (95% CI: 1.4-2.9) compared to group LIA with 1.6 (95% CI: 1.0-2.3) (Table 2).
However, average pain NRS at rest was slightly lower in group LIA, the small difference did not
show statistical significance (p-value not reported). The average pain NRS upon movement
between groups F and LIA similarly showed comparable results, and therefore not yielding
statistical significance between the control and experimental. The secondary outcome, total
morphine (in milligrams) consumption in the first 24 hours postoperatively, also yielded similar
amounts in both groups, indicating similar analgesic effects for both methods and did not reach
statistical significance.5 Total morphine (mg) per kilogram in group F was 0.4 (95% CI: 0.3-0.5)
whereas group LIA was 0.3 (95% CI: 0.2-0.4). Statistical significance was found for an NRS
score greater than 7 upon movement, as for group LIA, only 1 of 20 patients compared to group
F where 7 of 19 patients reported these values (p-value 0.04). Further studies need to be
conducted to explore and confirm this clinical finding.5 The Number Needed to Treat was
calculated to be 4, therefore for every 4 patients, 1 more patient had reduced pain intensity (NRS
score) at rest as compared to the control or femoral block analgesia (Table 4).
Table 2: Primary outcome comparing average pain NRS at rest and upon movement between
femoral block and LIA5
Average pain NRS at rest
Average pain NRS upon movement

Femoral block (n= 20)
2.1 (1.4-2.9)
2.4 (1.5 – 3.2)

LIA (n= 20)
1.6 (1.0 -2.3)
2.4 (1.7- 3.0)

Table 3: Secondary outcome comparing total morphine use (mg) between femoral block and
LIA5
Total morphine (mg)
Total morphine (mg/kg)

Femoral block (n=20)
32 (23-41)
0.4 (0.3 – 0.5)

LIA (n = 20)
24 (16-31)
0.3 (0.2 – 0.4)

Table 4: Pain intensity (NRS) at rest (throughout 24 h observation)
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CER
35%

EER
60%

Relative risk reduction
(RRR)
71.4%

Absolute risk
reduction (ARR)
60% - 35% = 25%

Number needed to
treat (NNT)
1/25% = 4

The second study (Essving et al) was conducted over a 3-month period postoperatively.
The 48 patients were randomized into group A (LIA) and group P (placebo) by the hospital
pharmacy (each group containing 24 patients); group A received 400 mg ropivacaine, 30 mg
ketorolac and 0.5 mg epinephrine periarticularly during the TKA and group P, no injections were
given. Twenty- one hours postoperatively, group A received 200 mg ropivacaine, 30 mg
ketorolac and 0.1 mg epinephrine intraarticularly and group P received the same volume of
saline.6
One of the 48 randomized patients in group P was withdrawn from the analysis of the
study due to disorientation postoperatively. Results were deemed statistically significant at a pvalue <0.05. Statistical significance was found for the primary endpoint of median morphine
consumption during the first 48 hours postoperatively in group A versus group P (p < 0.001)
with a median difference of 69 mg (95% CI: 47-86) (Table 5).6 The secondary endpoint, median
VAS pain score at rest and upon movement, was also found to be statistically significantly
reduced in group A compared to group P (Table 6).6 The pain intensity scores were recorded at
3, 6, 12, 21, 22 and 27 hours postoperatively.
Table 5: Consumption of analgesics6
Morphine IV (mg)
0-24 hrs
24-48 hrs
0-48 hrs
Tramadol orally (mg)
0-24 hrs
24-48 hrs
0-48 hrs
Total analgesicsa (mg)
0-48 hrs
a

Group A median (range)

Group P median (range)

p-value

17 (1-74)
0.5 (0-17)
18 (1-74)

65 (36 -131)
22 (0-52)
87 (36-160)

< 0.001
< 0.001
< 0.001

0 (0-200)
375 (0-400)
400 (0-500)

0 (0-100)
200 (0-200)
200 (0-500)

0.01
0.04
0.008

54 (4-114)

109 (37 -211)

< 0.001

Total analgesic consumption was calculated by converting oral tramadol to the equivalent dose
of IV morphine (100 mg tramadol orally = 10 mg morphine IV).6
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Table 6: Postoperative pain ratings VAS (0-100 mm) significance at rest and on flexion 60°
between Group A and Group P6
Time (hrs) post-operative

VAS at rest (p-value)

3
6
12
21
22
27

< 0.001
< 0.001
< 0.001
0.005
0.003
0.002

VAS on flexion 60° (pvalue)
< 0.001
< 0.001
< 0.001
N/A
< 0.001
0.005

The third and final study (Andersen et al) exhibits efficacy of LIA by demonstrating
reduced morphine consumption and pain intensity postoperatively (48 h following TKA) as
compared to the control group which employed continuous epidural infusion combined with
intravenous ketorolac treatment. Of the 40 patients in the study, 21 were analyzed in group A
[intraoperative wound infiltration with 150 mL ropivacaine (2 mg/mL), 1 mL ketorolac (30
mg/mL), and 0.3 mL epinephrine (1 mg/mL) combined with intraarticular infusion (4 mL/h) of
190 ropivacaine (2 mg/mL) plus 2 mL ketorolac (30 mg/mL)] compared to group E which
received epidural infusion [(4 mL/h) of 192 mL ropivacaine (2 mg/mL) combined with 6
intravenous administrations of 0.3 mL ketorolac (30 mg/mL)] for 24 hours postoperatively.7 The
statistical analysis used p-values to determine significance at 3 different time intervals in the
post-operative period and showed statistical significance for the reduction in pain intensity scores
and morphine consumption in favor of LIA therapy. P-values of <0.05 were considered
statistically significant. Morphine consumption during the 0-48 hour postoperative period was
statistically significantly reduced in group A compared to group E with a p-value of 0.01 (Table
7).7 Pain intensity was measured using a visual analog scale (VAS) scoring from 0-100 mm at
select intervals postoperatively. The experimental group A was found to have statistically
significant reduction in pain intensity postoperatively at rest and upon movement at 2-24 hours,
24-48 hours, and 48-72 hours postoperatively (Table 8).
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Table 7: Total Morphine consumption postoperatively (mg)7
Time Postoperatively
0-24 h
24-48 h
0-48 h

Group A (n=21)
7.5 (2.5-15)
5 (0-8.8)
11 (3.8 – 23)

Group E (n= 19)
18 (13-32)
15 (5-23)
33 (20-40)

p-value
0.05
0.03
0.01

Table 8: Pain Intensity score (VAS, 0-100 mm) at rest and during walking postoperatively7
Rest:

2-24 h
24-48 h
48-72 h
Walking: 2-24 h
24-48 h
48-72 h

Group A (n =21)
7 (3-25)
5 (2-21)
7.5 (2.5-21)
13 (4-41)
14 (7-35)
17 (4.5-36)

Group E (n= 19)
30 (10-44)
33 (9-38)
23 (14-42)
37 (12-53)
41 (27-51)
41 (24-53)

p-value
0.009
0.02
0.02
0.05
0.02
0.02

SAFETY
In the study by Affas et al, it was reported that none of the patients in the study endured
cardiac side effects to either of the control or experimental interventions (no patients had
prolonged QT interval at the ECG 2 hours and 24 hours postoperatively).5 In the study by
Essving et al, no major surgical complications were reported, as well as a statistically significant
lower incidence of nausea, pruritus and sedation in group A compared to group P (Table 9).6 The
most common side effect, nausea, had a number needed to harm (NNH) of -3, which means for
every 3 people treated with LIA, one less person experiences nausea as compared to the placebo.
Table 9 displays others adverse events of LIA therapy compared to the placebo. A negative NNH
value actually correlates with fewer ADRs for the experimental compared to the control. In the
study by Andersen et al, the adverse events reported included nausea, vomiting, and pruritus, and
were similar between both control and experimental groups.7 Group A (LIA) had significantly
lower incidence of constipation (p= 0.004) and shorter time with urinary retention (p= 0.03).7
One patient in Group A also developed a deep infection after spinal abscess; two patients in
group E were treated with antibiotics due to wound complications during the follow-up period.7
Table 9: Analysis of ADRs among placebo and experimental group in RCT by Essving et al6
Side effect (0-24 hrs

Relative Risk

Absolute Risk

Number Needed to

P-value
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post-operatively)
Nausea (0-24 hrs)
Vomiting (0-24 hrs)
Pruritus (0-24 hrs)
Sedation (0-24 hrs)

Increase (RRI)
-0.46
-0.46
-0.9
-1

Increase (ARI)
-32.5
-0.18
-0.35
-0.22

Harm (NNH)
-3
-6
-3
-5

0.03
0.2
0.004
0.02

DISCUSSION
This systematic review investigated three randomized controlled trials for the safety and
effectiveness of local infiltration analgesia as a postoperative pain management method after
unilateral TKA. The studies by Essving et al and Andersen et al demonstrated local infiltration
analgesia as a safe and effective means of postoperative pain management. Statistical
significance was not reached in the study conducted by Affas et al, however, a NNT of 4 and
paucity of adverse reactions demonstrates LIA as a safe and efficacious method of postoperative
analgesia.5
Local infiltration analgesia (LIA) is a multimodal method of postoperative pain
management following lower extremity orthopedic surgical procedures (total knee and hip
arthroplasties).8 This analgesic technique has gained attention and popularity among the
orthopedic world since its introduction by Kerr and Kohan in 2008.8 Currently, the most
commonly used methods of intraoperative analgesia during a TKA include an indwelling
epidural catheter and long-acting femoral nerve blocks. Epidural analgesia has proved its
efficacy as a postoperative pain management method following TKA, however not without
common side effects including urinary retention, hypotension and muscular weakness.5 Femoral
nerve blocks provide adequate postoperative analgesia as well, but can cause an unpleasant
numbness of the lower extremity.5 Local infiltration analgesia has been called into question,
regarding a safe plasma level for the combination of local anesthetic agents infiltrated peri- and
intraarticularly.8 Concerns have also been presented regarding the risk of infection with the
presence of an indwelling intra-articular catheter. In the study by Essving et al, none of the
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patients had any evidence of systemic analgesic toxicity and no evidence of postoperative
infections in the 3-month follow-up period presented, helping reassure the questions of the LIA
method’s safety.6
A limitation of the RCTs chosen for this systematic review is the lack of detail regarding
significant side effects and safety of the LIA therapy drugs. Another limitation of the RCTs
chosen were the sample sizes; each of the RCTs had between 40-48 patients participating, which
in the future, may necessitate further studies to solidify the evidence of LIA efficacy. Also, only
one of the RCTs was double-blinded, where two studies were not (Affas and Andersen), which
may have interfered with the patients and operators postoperative expectations.
CONCLUSION
Statistical significance for local infiltration analgesia’s superiority to femoral nerve block
analgesia was not seen statistically in the RCT by Affas et al, however the other two RCTs
(Essving and Andersen) indicated that LIA provided safe and effective postoperative pain
management compared to placebo infiltration and epidural analgesia (statistical significance p <
0.05).5,6,7 Therefore, I agree with such studies in that local infiltration analgesia is a safe and
effective method for postoperative pain management after unilateral total knee arthroplasty, as
revealed by this review. Future studies should focus on accumulating more participants to
increase credibility of the study as well as delve further into determining the appropriate dose for
patient safety of the locally infiltrated analgesic agents. Due to the rapidly increasing average
age of our US population, total knee arthroplasties have become a prevalent surgical procedure
in our society. The low cost of LIA and ease of administration should also be taken into
consideration when the surgical team and patient are consulting regarding postoperative pain
management.
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